LSTA
Lisata Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.65
+0.61%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-51.0%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jan 13, 2026 | Imam Tariq · officer: SVP, Bus Dev, General Counsel | F-InKind | 1,401 | $1.97 |
| Jan 13, 2026 | Mazzo David J · director, officer: President & CEO | A-Award | 81,000 | $0.00 |
| Jan 13, 2026 | Mazzo David J · director, officer: President & CEO | F-InKind | 10,503 | $1.97 |
| Jan 13, 2026 | Mazzo David J · director, officer: President & CEO | F-InKind | 10,515 | $1.97 |
| Jan 13, 2026 | Mazzo David J · director, officer: President & CEO | F-InKind | 12,224 | $1.97 |
| Jan 13, 2026 | Mazzo David J · director, officer: President & CEO | F-InKind | 7,854 | $1.97 |
| Jan 13, 2026 | Mazzo David J · director, officer: President & CEO | A-Award | 40,000 | $1.97 |
| Jan 13, 2026 | Nisco James · officer: SVP, Fin/Treas, Chief Actg Off | A-Award | 15,000 | $0.00 |
| Jan 13, 2026 | Nisco James · officer: SVP, Fin/Treas, Chief Actg Off | F-InKind | 2,131 | $1.97 |
| Jan 13, 2026 | Nisco James · officer: SVP, Fin/Treas, Chief Actg Off | F-InKind | 1,137 | $1.97 |
| Jan 13, 2026 | Nisco James · officer: SVP, Fin/Treas, Chief Actg Off | F-InKind | 781 | $1.97 |
| Jan 13, 2026 | Nisco James · officer: SVP, Fin/Treas, Chief Actg Off | A-Award | 7,000 | $1.97 |
| Jan 13, 2026 | Imam Tariq · officer: SVP, Bus Dev, General Counsel | A-Award | 15,000 | $0.00 |
| Jan 13, 2026 | Imam Tariq · officer: SVP, Bus Dev, General Counsel | F-InKind | 840 | $1.97 |
| Jan 13, 2026 | Imam Tariq · officer: SVP, Bus Dev, General Counsel | F-InKind | 747 | $1.97 |
| Jan 13, 2026 | Imam Tariq · officer: SVP, Bus Dev, General Counsel | F-InKind | 513 | $1.97 |
| Jan 13, 2026 | Imam Tariq · officer: SVP, Bus Dev, General Counsel | A-Award | 7,000 | $1.97 |
| Jan 13, 2026 | Buck Kristen K · officer: EVP, R&D and CMO | A-Award | 25,000 | $0.00 |
| Jan 13, 2026 | Buck Kristen K · officer: EVP, R&D and CMO | F-InKind | 2,982 | $1.97 |
| Jan 13, 2026 | Buck Kristen K · officer: EVP, R&D and CMO | F-InKind | 3,221 | $1.97 |
| Jan 13, 2026 | Buck Kristen K · officer: EVP, R&D and CMO | F-InKind | 2,147 | $1.97 |
| Jan 13, 2026 | Buck Kristen K · officer: EVP, R&D and CMO | A-Award | 13,000 | $1.97 |
| Jan 13, 2026 | KLOSK STEVEN M · director | A-Award | 30,456 | $0.00 |
| Jan 13, 2026 | HENSON HEIDI · director | A-Award | 30,456 | $0.00 |
| Jan 13, 2026 | Flowers Cynthia Louise · director | A-Award | 30,456 | $0.00 |
| Jan 13, 2026 | BROWN GREGORY B · director | A-Award | 30,456 | $0.00 |
| Jan 13, 2026 | AZAB MOHAMMAD · director | A-Award | 30,456 | $0.00 |
| Jan 13, 2025 | Flowers Cynthia Louise · director | A-Award | 15,789 | $0.00 |
| Jan 13, 2025 | AZAB MOHAMMAD · director | A-Award | 15,789 | $0.00 |
| Jan 13, 2025 | Nisco James · officer: SVP, Fin/Treas, Chief Actg Off | A-Award | 15,000 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 14Increased 5Reduced 5Sold out 33
| Filer | Action | Shares | Filed |
|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 271,815 | May 15, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | Increased | 131,715 | May 14, 2026 |
| DELTEC ASSET MANAGEMENT LLC | New Position | 90,000 | Apr 24, 2026 |
| RANGELEY CAPITAL, LLC | New Position | 75,000 | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 70,887 | May 15, 2026 |
| CSS LLC/IL | New Position | 61,898 | May 15, 2026 |
| BLACKROCK, INC. | Unchanged | 54,857 | May 13, 2026 |
| PENDERFUND CAPITAL MANAGEMENT LTD. | New Position | 47,500 | May 15, 2026 |
| VIRTU FINANCIAL LLC | New Position | 42,213 | May 14, 2026 |
| VANGUARD FIDUCIARY TRUST CO | New Position | 34,917 | May 8, 2026 |
| GTS SECURITIES LLC | New Position | 31,396 | May 15, 2026 |
| STATE STREET CORP | Increased | 25,348 | May 15, 2026 |
| CITADEL ADVISORS LLC | New Position | 22,666 | May 15, 2026 |
| CITADEL ADVISORS LLC | Reduced | 15,541 | Sep 2, 2026 |
| JBF CAPITAL, INC. | New Position | 13,234 | May 8, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jan 13, 2026